NASDAQ · Healthcare · Biotechnology
Altimmune, Inc.
ALT
Altimmune, Inc. CEO Jerome Benedict Durso · Market cap $260.3M.
$2.95
-0.13 · -4.23%
52w hi $7.7352w lo $2.56
Off 52w high 63.1%
74
NOTABLE
Current InsiderScore
Corp · 90d
4
4 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
5
0 strong · 5 notable
Analyst consensus
Strong Buy
Avg PT $11.25
Section 01
Recent Form 4 filings
6 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Apr 06 | John Gill | Buy | 9,200 | $3.41 | +$31K | 58 | |
| Apr 01 | Jerome Benedict Durso | President and CEO | Buy | 15,000 | $3.14 | +$47K | 74 |
| Apr 01 | Gregory L Weaver | Chief Financial Officer | Buy | 10,000 | $3.15 | +$31K | 71 |
| Mar 06 | Jerome Benedict Durso | President and CEO | Buy | 20,000 | $3.54 | +$71K | 69 |
| Dec 23 | John Gill | Buy | 12,500 | $4.10 | +$51K | 60 | |
| Dec 22 | Jerome Benedict Durso | Buy | 12,500 | $4.13 | +$52K | 60 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay